• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Hospira

Hospira

Hospira Inc HSP 3 Star

Last Price$88.27Day Change (%)-0.05%
Open Price$88.19Day Change ($)-0.04
Day Range88.16–88.4552-Week Range46.56–88.45

As of Fri 5/22/2015 5:25:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: 10 companies with the biggest earnings surprises

    UPDATE: 10 companies with the biggest earnings surprises

  2. UPDATE: 10 companies with the biggest earnings surprises

    UPDATE: 10 companies with the biggest earnings surprises

  3. Research and Markets: Tuberculosis Testing Market - Global Industry Analysis 2014-2020

    Research and Markets: Tuberculosis Testing Market - Global Industry Analysis 2014-2020

  4. Research and Markets: Global Active Pharmaceutical Ingredients (API) Market 2014-2020: Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured

    Research and Markets: Global Active Pharmaceutical Ingredients (API) Market 2014-2020: Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured

  5. Research and Markets: Europe Markets for Infusion Therapy Devices 2015

    Research and Markets: Europe Markets for Infusion Therapy Devices 2015

  6. Pfizer's Acquisition of Hospira Strengthens Its Moat at a Fair Price

    Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.

  7. Pfizer profit, revenue top estimates, but lowers outlook on strong dollar

    Pfizer profit, revenue top estimates, but lowers outlook on strong dollar

  8. Hospira HSP Q1 2014 Earnings Call Transcript

    Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.

  9. Bull Market: More to Run

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.